JP2011530536A5 - - Google Patents

Download PDF

Info

Publication number
JP2011530536A5
JP2011530536A5 JP2011522288A JP2011522288A JP2011530536A5 JP 2011530536 A5 JP2011530536 A5 JP 2011530536A5 JP 2011522288 A JP2011522288 A JP 2011522288A JP 2011522288 A JP2011522288 A JP 2011522288A JP 2011530536 A5 JP2011530536 A5 JP 2011530536A5
Authority
JP
Japan
Prior art keywords
antibody
fragment
seq
pancreatic cancer
panin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522288A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011530536A (ja
JP5919604B2 (ja
Filing date
Publication date
Priority claimed from US12/343,655 external-priority patent/US7993626B2/en
Priority claimed from US12/418,877 external-priority patent/US7906118B2/en
Application filed filed Critical
Priority claimed from PCT/US2009/053192 external-priority patent/WO2010017500A2/en
Publication of JP2011530536A publication Critical patent/JP2011530536A/ja
Publication of JP2011530536A5 publication Critical patent/JP2011530536A5/ja
Application granted granted Critical
Publication of JP5919604B2 publication Critical patent/JP5919604B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522288A 2008-08-08 2009-08-07 抗膵癌抗体 Expired - Fee Related JP5919604B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US8746308P 2008-08-08 2008-08-08
US61/087,463 2008-08-08
US12/343,655 2008-12-24
US12/343,655 US7993626B2 (en) 2007-01-11 2008-12-24 Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US14422709P 2009-01-13 2009-01-13
US61/144,227 2009-01-13
US12/418,877 2009-04-06
US12/418,877 US7906118B2 (en) 2005-04-06 2009-04-06 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
PCT/US2009/053192 WO2010017500A2 (en) 2008-08-08 2009-08-07 Anti-pancreatic cancer antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015009665A Division JP2015110618A (ja) 2008-08-08 2015-01-21 抗膵癌抗体

Publications (3)

Publication Number Publication Date
JP2011530536A JP2011530536A (ja) 2011-12-22
JP2011530536A5 true JP2011530536A5 (cg-RX-API-DMAC7.html) 2012-08-23
JP5919604B2 JP5919604B2 (ja) 2016-05-18

Family

ID=41664221

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011522288A Expired - Fee Related JP5919604B2 (ja) 2008-08-08 2009-08-07 抗膵癌抗体
JP2015009665A Pending JP2015110618A (ja) 2008-08-08 2015-01-21 抗膵癌抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015009665A Pending JP2015110618A (ja) 2008-08-08 2015-01-21 抗膵癌抗体

Country Status (6)

Country Link
EP (1) EP2331134A4 (cg-RX-API-DMAC7.html)
JP (2) JP5919604B2 (cg-RX-API-DMAC7.html)
CN (1) CN102137681B (cg-RX-API-DMAC7.html)
AU (1) AU2009279503B2 (cg-RX-API-DMAC7.html)
CA (1) CA2731438C (cg-RX-API-DMAC7.html)
WO (1) WO2010017500A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481041B2 (en) 2005-04-06 2013-07-09 Ibc Pharmaceuticals, Inc. Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
RU2012148816A (ru) * 2010-05-07 2014-06-20 Ф. Хоффманн-Ля Рош Аг Метод диагностики для определения клеток ex vivo
EP2635300A4 (en) * 2010-11-03 2014-04-02 Ibc Pharmaceuticals Inc DOCK-AND-LOCK (DNL) CONSTRUCTS FOR THERAPY AGAINST HUMAN IMMUNE WEAKAGE VIRUS (HIV)
CA2814962A1 (en) * 2010-12-02 2012-06-07 Immunomedics, Inc. In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
CN102485753A (zh) * 2010-12-03 2012-06-06 上海杰隆生物工程股份有限公司 具有人血管内皮生长因子结合活性的人源重链可变区
SG11201402364WA (en) * 2011-11-15 2014-09-26 Quincy Bioscience Llc Apoaequorin for reducing neuronal injury due to ischemia
CN107753954A (zh) * 2012-12-13 2018-03-06 免疫医疗公司 功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量
EP2981829A4 (en) * 2013-04-01 2016-10-26 Immunomedics Inc ANTI-MUCIN ANTIBODY FOR THE EARLY RECOGNITION AND TREATMENT OF PANCREATIC CANCER
CN105073128A (zh) * 2013-04-03 2015-11-18 Ibc药品公司 用于诱导对疾病的免疫应答的组合疗法
EP3015864A4 (en) * 2013-06-14 2017-01-18 Universidad de Granada Biomarkers for the diagnosis and the response to treatment of pancreatic cancer
KR20150129932A (ko) * 2014-05-12 2015-11-23 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
EP3160499A4 (en) * 2014-06-30 2018-03-14 Immunomedics, Inc. Antibodies reactive with an epitope located in the n-terminal region of muc5ac comprising cysteine-rich subdomain 2 (cys2)
KR20160045547A (ko) * 2014-10-17 2016-04-27 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
CN104974988B (zh) * 2015-07-31 2016-08-24 南京麦科林生物医药科技有限公司 抗胰腺癌单克隆抗体及其应用
TW202005667A (zh) * 2018-04-05 2020-02-01 美商塔維達治療公司 Hsp90-靶向共軛體及其調合物
WO2020055768A1 (en) * 2018-09-10 2020-03-19 Cold Spring Harbor Laboratory Methods for treating pancreatitis
PH12022550894A1 (en) * 2019-10-18 2023-03-27 Nihon Mediphysics Co Ltd Ri-labeled humanized antibody
IL303002B1 (en) * 2020-12-16 2026-08-01 Alpha Tau Medical Ltd Radiation therapy using scattered alpha emitters with enhanced beta therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6357596A (ja) * 1986-08-29 1988-03-12 Nisshin Flour Milling Co Ltd モノクロ−ナル抗体、その製法およびそれからなる肝疾患診断剤
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
ES2524767T3 (es) * 2002-06-14 2014-12-12 Immunomedics, Inc. Anticuerpo monoclonal humanizado HPAM4
US20080171067A1 (en) * 2007-01-17 2008-07-17 Immunomedics, Inc. Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
AU2006232310B9 (en) * 2005-04-06 2011-07-21 Ibc Pharmaceuticals, Inc. Improved stably tethered structures of defined compositions with multiple functions or binding specificities

Similar Documents

Publication Publication Date Title
ES2994774T3 (en) Methods for preventing or treating allergy by administering an il-4r antagonist
TWI856945B (zh) 用抗tslp抗體治療氣喘
US20200399384A1 (en) Method of treating diseases using an il-17 receptor antibody formulation
US8846002B2 (en) Anti-CD74 immunoconjugates and methods of use
KR101927118B1 (ko) Gd2 양성암의 치료 방법
JP2020188775A (ja) プロラクチン受容体結合タンパク質およびそれらの使用
ES2547689T3 (es) Composiciones y métodos para el tratamiento de enfermedades y trastornos asociados con la señalización de citocinas que implican anticuerpos que se unen a IL-22 y a IL-22R
JP2020516647A5 (cg-RX-API-DMAC7.html)
AU2020266593B2 (en) Methods for treating or preventing asthma by administering an IL-33 antagonist
JP2009538284A5 (cg-RX-API-DMAC7.html)
RU2005100777A (ru) Моноклональное антитело рам4 и его применение для диагностики и лечения рака поджелудочной железы
JP2008520551A5 (cg-RX-API-DMAC7.html)
JP6596014B2 (ja) 爪および頭皮乾癬の治療方法
JP2006502698A5 (cg-RX-API-DMAC7.html)
JP2026505129A (ja) 抗cdh17抗体及びその使用
KR20220002899A (ko) 항-psma/cd3 항체로 전립선암을 치료하는 방법
Amini-Vaughan et al. Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer
WO2021249445A1 (zh) 抗il-17a抗体药物组合物及其用途
US20210230265A1 (en) Methods for treating copd by administering an il-33 antagonist
Desai et al. Biologics in asthma: emerging biologics
CN120958023A (zh) 通过阻断il-13和tslp治疗哮喘
Liu et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of firsekibart, an anti-interleukin-1β monoclonal antibody, in healthy Chinese participants: a randomized, double-blind, placebo-controlled phase 1 study
KR20220002900A (ko) 항-psma/cd3 항체로 신장암을 치료하는 방법
CN117467011A (zh) 一种抗FcRn抗体及其制剂与应用
CN110582702A (zh) 使用il-17拮抗剂选择性治疗哮喘的方法